Interleukin 6 Blockade as Steroid-sparing Treatment for 2 Patients with Giant Cell Arteritis

被引：51
|
作者：
Sciascia, Savino [1 ]
Rossi, Daniela [1 ]
Roccatello, Dario [1 ]
机构：
[1] Univ Turin, Ctr Ric Immunopatol & Documentaz Malatti Rare CMI, Dipartimento Malattie Rare Immunol Ematol & Immun, Direz Univ Immunol Clin Osped, I-10154 Turin, Italy
来源：
JOURNAL OF RHEUMATOLOGY | 2011年 / 38卷 / 09期
关键词：
PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; METHOTREXATE; ARTHRITIS;
D O I：
10.3899/jrheum.110496
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2080 / 2082
页数：3
相关论文
共 50 条
  • [41] Treatment of giant cell arteritis - Interleukin-6 as a biologic marker of disease activity
    Weyand, CM
    Fulbright, JW
    Hunder, GG
    Evans, JM
    Goronzy, JJ
    ARTHRITIS AND RHEUMATISM, 2000, 43 (05): : 1041 - 1048
  • [42] Anti-interleukin 6 receptor therapy as rescue treatment for giant cell arteritis
    Beyer, Christian
    Axmann, Roland
    Sahinbegovic, Enijad
    Distler, Joerg H.
    Manger, Bernhard
    Schett, Georg
    Zwerina, Jochen
    ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (10) : 1874 - 1875
  • [43] Mepolizumab as a steroid-sparing treatment option in patients with Churg-Strauss syndrome
    Kim, Sophia
    Marigowda, Gautham
    Oren, Eyal
    Israel, Elliot
    Wechsler, Michael E.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 125 (06) : 1336 - 1343
  • [44] INTERLEUKIN-6 INHIBITION WITH TOCILIZUMAB FOR THE TREATMENT OF GIANT CELL ARTERITIS AND POLYMYALGIA RHEUMATICA IN PATIENTS WITH SERIOUS COMORBIDITIES
    Beketova, T.
    Otteva, E.
    Nasonov, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1524 - 1525
  • [45] STEROID-SPARING EFFECT OF ALOMIDE(R) IN PATIENTS WITH VKC
    DOBBS, R
    BERTIN, D
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1994, 35 (04) : 1290 - 1290
  • [46] INTERLEUKIN-6 IN SERUM OF PATIENTS WITH POLYMYALGIA RHEUMATICA AND GIANT-CELL ARTERITIS
    DASGUPTA, B
    PANAYI, GS
    BRITISH JOURNAL OF RHEUMATOLOGY, 1990, 29 (06): : 456 - 458
  • [47] Low-dose methotrexate as a steroid-sparing agent in a child with Takayasu's arteritis
    Shetty, AK
    Stopa, AR
    Gedalia, A
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1998, 16 (03) : 335 - 336
  • [48] Steroid management in giant cell arteritis
    Chan, CCK
    Paine, M
    O'Day, J
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2001, 85 (09) : 1061 - 1064
  • [49] Comparison of methotrexate and azathioprine as the first-line steroid-sparing immunosuppressive agents in patients with Takayasu ' s arteritis
    Kaymaz-Tahra, Sema
    Bayindir, Ozun
    Ince, Burak
    Isik, Ozlem Ozdemir
    Kutu, Muhammet Emin
    Karakas, Ozlem
    Yildirim, Tuba Demirci
    Ademoglu, Zeliha
    Ediboglu, Elif Durak
    Uludogan, Burcu Ceren Ekti
    Ilgin, Can
    Bilge, Nazife Sule Yasar
    Kasifoglu, Timucin
    Akar, Servet
    Emmungil, Hakan
    Onen, Fatos
    Omma, Ahmet
    Kanitez, Nilufer Alpay
    Yazici, Ayten
    Cefle, Ayse
    Inanc, Murat
    Aksu, Kenan
    Keser, Gokhan
    Direskeneli, Haner
    Alibaz-Oner, Fatma
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2024, 66
  • [50] Mepolizumab as a Steroid-Sparing Treatment in the Churg Strauss Syndrome.
    Kim, S. H.
    Israel, E.
    Oren, E.
    Wechsler, M. E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
12345